Autism

Healio Psychiatry has compiled a list of its five most-viewed stories in May.

Early emerging autism spectrum disorder symptom levels often declined across development, according to an analysis of a prospective population-based cohort published in American Journal of Psychiatry.

The beta-blocker propranolol showed potential in treating certain autism symptoms, according to an initial analysis of a small, double-blinded, placebo-controlled trial.

School-aged children with autism spectrum disorder and/or ADHD were capable of face covering across activities during the COVID-19 pandemic, according to results of a cohort study published in JAMA Network Open.

This April marks the first Autism Acceptance Month, according to the Autism Society.

A Canadian study of more than 123,000 births found no association between epidural labor analgesia exposure and an increased risk for autism spectrum disorder in children, according to findings published in JAMA Pediatrics.

A new study reinforces previous reports that lower vitamin D levels are associated with an increased risk for developing COVID-19, especially among Black adults. It was the top story in endocrinology last week.

Children with autism spectrum disorder are vulnerable to developing substance use disorder, according to a study published in JAMA Pediatrics.

Caregiver-reported mental health conditions were prevalent among children with autism spectrum disorder in the United States from a young age, according to study results published in Journal of Clinical Psychiatry.

Individuals with schizophrenia spectrum disorders or autism spectrum disorders may have similar levels of social cognitive impairment, according to study results published in JAMA Psychiatry.